Blogs
Randomized controlled trials (RCTs) are the gold standard of evidence for establishing the value of an intervention and obtaining regulatory approval. However, patient-level RCT data from legacy trials is not available for further hypothesis testing and analysis. Read more
Randomized controlled trials (RCTs) are the gold standard of evidence for establishing the value of an intervention and obtaining regulatory approval. However, patient-level RCT data from legacy trials is not available for further hypothesis testing and analysis. Read more
Cytokine storm is an uncontrolled release of cytokines in the body in response to external stimuli leading to systemic inflammation. Ferrara et al. (1993) first coined the term “cytokine storm” in graft-versus-host disease. Approximately, 15.7% of COVID-19 patients develop severe pneumonia and cytokine storm. Read more
The ongoing COVID-19 pandemic is continuing to spread rapidly across the globe. As of 7th Feb 2021, the World Health Organization (WHO) has reported over 105 million cases and over 2 million deaths across 219 countries. Read more
Target identification is an essential first step toward the discovery and development of any new therapeutic. Consequently, successful pharma organizations perform due diligence around a target of interest before embarking on the long, time-consuming, expensive and high-risk endeavor of drug Read more
Traditional techniques of Data Cataloging at a data storage level creates dispersed data silos across the enterprise. An intelligent automated Data Catalog linked to diverse and distributed data storages will enable effective data governance through Read more
Immune overreaction to a viral infection can lead to a Cytokine storm. It may also result in serious complications such as pneumonia and acute respiratory distress syndrome (ARDS). Read more
Drug repurposing or repositioning is a promising approach for identifying new indications for approved or investigational (including clinically failed) drugs that have not been approved by FDA. Read more
Remdesivir, is an antiviral medication being developed by Gilead Sciences for the treatment for Ebola virus disease. Animal studies have found it to be active against SARS and MERS viruses. Read more
The coronavirus (COVID-19) pandemic has proven to be a formidable scientific, medical, and social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is centered on the unpredictable clinical course of the disease that can rapidly develop, causing severe and deadly complications. Read more